Keenova Therapeutics plc insider trading.
In Q3 2026, insiders at Keenova Therapeutics plc reported 5 non-derivative transactions on 12 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 4
- Last filed
- 2026-07-23
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Donato Leslie E | Director | 2 | 0 | 0 |
| Stouch Cheryl Ann | Officer · EVP & Chief Info Officer | 1 | 0 | 0 |
| Basso Tracy | Officer · EVP & CHRO | 1 | 0 | 0 |
| Williamson Susan Ann | Officer · EVP & Chief Compliance Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-21 | Stouch Cheryl Ann | F (D) | 328 | — | 1,440 | Form 4 |
| 2026-07-21 | Basso Tracy | F (D) | 763 | — | 1,542 | Form 4 |
| 2026-07-21 | Williamson Susan Ann | F (D) | 571 | — | 1,460 | Form 4 |
| 2026-06-02 | Donato Leslie E | F (D) | 619 | — | 2,066 | Form 4/A |
| 2026-06-02 | Donato Leslie E | M (A) | 2,685 | — | 2,685 | Form 4/A |
Transaction codes in this quarter
Get Keenova Therapeutics plc insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1567892&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · Keenova Therapeutics plc on SEC.gov
Questions
Are insiders buying or selling Keenova Therapeutics plc?
In Q3 2026, insiders at Keenova Therapeutics plc reported 5 non-derivative transactions on 12 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Keenova Therapeutics plc insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/1567892.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.